Inventor · disambiguated record
Christopher W. Boyce
Also filed as: BOYCE CHRISTOPHER · BOYCE CHRISTOPHER W
31 granted patents·7 pending applications·181 citations·filing 2001–2022
96Inventor score
Files withMERCK SHARP & DOHME12SCHERING CORP11BOYCE CHRISTOPHER W4MCCORMICK KEVIN D3SCHERING PLOUGH CORP2
Top patents by PatentIndex Score
38 records- 0190US7638531B2Phenoxypiperidines and analogs thereof useful as histamine H3 antagonistsSCHERING CORP·Filed 2006·Granted Dec 29, 2009·19 cites·18 claims
- 0290US7105505B2Benzimidazole derivatives useful as histamine H3 antagonistsSCHERING CORP·Filed 2003·Granted Sep 12, 2006·27 cites·22 claims
- 0389US6720328B2Non-imidazole compoundsSCHERING CORP·Filed 2001·Granted Apr 13, 2004·31 cites·43 claims
- 0488US8003624B2Functionally selective ALPHA2C adrenoreceptor agonistsSCHERING CORP·Filed 2007·Granted Aug 23, 2011·11 cites·7 claims
- 0587US7220735B2Benzimidazolone histamine H3 antagonistsSCHERING CORP·Filed 2003·Granted May 22, 2007·31 cites·18 claims
- 0685US7803828B2Functionally selective alpha2C adrenoreceptor agonistsSCHERING PLOUGH CORP·Filed 2006·Granted Sep 28, 2010·9 cites·17 claims
- 0784US7700592B2α2C adrenoreceptor agonistsSCHERING CORP·Filed 2007·Granted Apr 20, 2010·8 cites·11 claims
- 0881US10011615B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist propertiesMERCK SHARP & DOHME·Filed 2017·Granted Jul 3, 2018·3 cites·14 claims
- 0981US9023865B2Compounds that are ERK inhibitorsLIM JONGWON·Filed 2012·Granted May 5, 2015·4 cites·20 claims
- 1081US8383818B2Functionally selective alpha2C adrenoreceptor agonistsMERCK SHARP & DOHME·Filed 2009·Granted Feb 26, 2013·5 cites·4 claims
- 1181US7300941B2Non-imidazole compoundsSCHERING CORP·Filed 2003·Granted Nov 27, 2007·11 cites·2 claims
- 1279US7846946B2Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonistsSCHERING PLOUGH CORP·Filed 2009·Granted Dec 7, 2010·3 cites·2 claims
- 1378US8927559B2Quinazolinone-type compounds as CRTH2 antagonistsASLANIAN ROBERT G·Filed 2011·Granted Jan 6, 2015·6 cites·16 claims
- 1475US7635705B2Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonistsSCHERING CORP·Filed 2006·Granted Dec 22, 2009·2 cites·19 claims
- 1573US9884048B2ERK inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Feb 6, 2018·2 cites·6 claims
- 1673US9676780B2Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jun 13, 2017·2 cites·15 claims
- 1772US9469615B2Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Oct 18, 2016·4 cites·27 claims
- 1872US7985748B2ALPHA2C adrenoreceptor agonistsPHARMACOPEIA DRUG DISCOVERY·Filed 2010·Granted Jul 26, 2011·2 cites·15 claims
- 1966US8324213B2Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulatorsMCCORMICK KEVIN D·Filed 2009·Granted Dec 4, 2012·1 cites·11 claims
- 2064US9745307B2Compounds that are ERK inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 29, 2017·0 cites·7 claims
- 2163US10759805B2Compounds that are ERK inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Sep 1, 2020·0 cites·14 claims
- 2260US10065967B2Compounds that are ERK inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Sep 4, 2018·0 cites·15 claims
- 2360US2008119487A1Novel non-imidazole compoundsSCHERING CORP·Filed 2007·Application pending·0 cites
- 2455US8569312B2Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2013·Granted Oct 29, 2013·0 cites·11 claims
- 2554US8476274B2Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2012·Granted Jul 2, 2013·0 cites·10 claims
- 2653US2023322785A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyBOYCE CHRISTOPHER W·Filed 2022·Application pending·0 cites
- 2752US2011190247A1Cyclopropylchromene derivatives as modulators of the alpha-2c receptorSCHERING CORP·Filed 2009·Application pending·0 cites
- 2851US8017642B2Functionally selective ALPHA2C adrenoreceptor agonistsSCHERING CORP·Filed 2008·Granted Sep 13, 2011·0 cites·10 claims
- 2951US2007093477A1Alpha2C adrenoreceptor agonistsSCHERING CORP AND PHARMACOPEIA·Filed 2006·Application pending·0 cites
- 3050US11344496B2Methods for preparing stabilized amorphous drug formulations using acoustic fusionMERCK SHARP & DOHME·Filed 2018·Granted May 31, 2022·0 cites·20 claims
- 3150US8470863B2Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonistsZHENG JUNYING·Filed 2008·Granted Jun 25, 2013·0 cites·14 claims
- 3249US2012028940A1Functionally selective azanitrile alpha-2c adrenoreceptor agonistsBOYCE CHRISTOPHER W·Filed 2009·Application pending·0 cites
- 3346US2011166124A1Tricyclic spirocycle derivatives and methods of useMCCORMICK KEVIN D·Filed 2009·Application pending·0 cites
- 3441US9233979B2Compounds that are ERK inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jan 12, 2016·0 cites·16 claims
- 3541US9226922B2Compounds that are ERK inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jan 5, 2016·0 cites·15 claims
- 3640US8501747B2Functionally selective alpha2C adrenoreceptor agonistsDE LERA RUIZ MANUEL·Filed 2008·Granted Aug 6, 2013·0 cites·7 claims
- 3738US9290453B2Quinolines and aza-quinolines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Mar 22, 2016·0 cites·12 claims
- 3832US2013079271A1Reversed biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulatorsMCCORMICK KEVIN D·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →